REG - Geiger Counter Ltd Geiger Counter - GCS - Net Asset Value(s)

Geiger CounterAnnouncement

09/12/2025 15:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251209:nRSI8839Ka&default-theme=true

RNS Number : 8839K  Geiger Counter Ltd  09 December 2025

 

Geiger Counter Limited

(the "Company")

Net Asset Value

 

Geiger Counter Limited (LSE: GCL) announces that as at the close of business
on 8 December 2025 its unaudited net asset value ("NAV") per ordinary share
("Share") was as follows:

 

 Date of announcement            09 December 2025
 Date of NAV                     08 December 2025
 NAV per share - undiluted       69.45 pence per share
 NAV per share - fully diluted*  64.08 pence per share
 No of voting shares in issue    105,836,041
 Subscription Exercise Price     37.20 pence per share
 Next Subscription Date          1 May 2026

 

*Notes relating to the NAV dilution

The dilution is in relation to the effect of the Company's embedded annual
Subscription Right. Shareholders should note that the dilution refers to the
NAV per share dilution, not to the dilution of Shareholders' holdings in the
Company. All Shareholders have the right to take up their subscription rights
on 1 May in each year and those who do take them up in full don't have their
percentage holding in the Company diluted. For those investors who don't take
up their subscription rights, the Company endeavours to place in the market
the shares that they were entitled to subscribe for, and then return the net
sale proceeds to those investors as a way to deliver to them as much as
possible of the value of their subscription rights, therefore reducing the
dilution effect of not subscribing.

 

About the annual Subscription Right

Shareholders have the right to subscribe for one new Ordinary Share for every
five Ordinary Shares held in the Company on the Record Date, as outlined in
the circular published on 31 March 2021. The exercise price is equal to the
undiluted NAV per share on 30 April one year prior. The aim of the programme
is to enable to Company to grow through share issuance and it is subject to
shareholder review at the annual general meeting ("AGM") in 2026 and at every
fifth subsequent AGM thereafter.

 

Enquiries

Manulife | CQS Investment Management

Craig Cleland +44 (0) 20 7201 5368

 

Cavendish Capital Markets Limited

Daniel Balabanoff / Pauline Tribe (Sales +44 (0) 20 7720 0500)

Tunga Chigovanyika (Corporate Finance Director +44 (0) 20 7397 1915)

 

Summit Fund Services Jersey Limited

Christopher Foulds +44 (0) 1534 825 259

 

About Geiger Counter Limited

 

Geiger Counter Limited is a closed-ended investment company incorporated with
limited liability in Jersey. The Company's investment objective is to provide
attractive returns to Shareholders principally in form of capital growth,
through investment in companies involved in the exploration, development and
production or uranium to supply the nuclear power industry.

 

For the latest factsheet and other information, click here
(https://ncim.co.uk/golden-prospect-precious-metals-ltd/) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NAVBUBDDDGGDGUC



            Copyright 2019 Regulatory News Service, all rights reserved